US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer.
Melanie E RoyceFlora MulkeyChristy OsgoodErik W BloomquistLaleh Amiri-KordestaniPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)